BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16077972)

  • 21. Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases.
    Yang J; McEachern D; Li W; Davis MA; Li H; Morgan MA; Bai L; Sebolt JT; Sun H; Lawrence TS; Wang S; Sun Y
    Mol Cancer Ther; 2011 Apr; 10(4):658-69. PubMed ID: 21282353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
    Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
    Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside.
    Basu S; Ma R; Boyle PJ; Mikulla B; Bradley M; Smith B; Basu M; Banerjee S
    Glycoconj J; 2004; 20(9):563-77. PubMed ID: 15454695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
    Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
    Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells.
    Kuwahara D; Tsutsumi K; Kobayashi T; Hasunuma T; Nishioka K
    Cancer Lett; 2000 Jan; 148(1):65-71. PubMed ID: 10680594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of IGF1R Expression Inhibits Growth and Enhances Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cells In Vitro.
    Khalil A; Jameson MJ
    Horm Cancer; 2019 Feb; 10(1):11-23. PubMed ID: 30350263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
    Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
    BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathway.
    Li R; Zang Y; Li C; Patel NS; Grandis JR; Johnson DE
    Mol Pharmacol; 2009 May; 75(5):1231-9. PubMed ID: 19246337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
    Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
    Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis.
    Ashimori N; Zeitlin BD; Zhang Z; Warner K; Turkienicz IM; Spalding AC; Teknos TN; Wang S; Nör JE
    Mol Cancer Ther; 2009 Apr; 8(4):893-903. PubMed ID: 19372562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane.
    Kotowski U; Heiduschka G; Brunner M; Czembirek C; Eder-Czembirek C; Schmidt R; Fahim T; Thurnher D
    Strahlenther Onkol; 2011 Sep; 187(9):575-80. PubMed ID: 21858418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells.
    Kim JS; Lee JH; Jeong WW; Choi DH; Cha HJ; Kim DH; Kwon JK; Park SE; Park JH; Cho HR; Lee SH; Park SK; Lee BJ; Min YJ; Park JW
    Int J Cancer; 2008 Feb; 122(3):672-80. PubMed ID: 17955488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goniothalamin induces cell cycle arrest and apoptosis in H400 human oral squamous cell carcinoma: A caspase-dependent mitochondrial-mediated pathway with downregulation of NF-κβ.
    Li LK; Rola AS; Kaid FA; Ali AM; Alabsi AM
    Arch Oral Biol; 2016 Apr; 64():28-38. PubMed ID: 26752226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma.
    Schnoell J; Stanisz I; Jank BJ; Stanek V; Schmid R; Brunner M; Heiduschka G; Kotowski U
    Invest New Drugs; 2022 Apr; 40(2):224-231. PubMed ID: 34613571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2.
    Park SB; Lee JH; Jeong WW; Kim YH; Cha HJ; Joe Y; Chung HT; Cho WJ; Do JW; Lee BJ; Park JW; Ko BK
    J Chemother; 2015 Jun; 27(3):174-80. PubMed ID: 25604244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors.
    Fulda S; Friesen C; Los M; Scaffidi C; Mier W; Benedict M; Nuñez G; Krammer PH; Peter ME; Debatin KM
    Cancer Res; 1997 Nov; 57(21):4956-64. PubMed ID: 9354463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells.
    Al-Hazzaa A; Bowen ID; Randerson P; Birchall MA
    Cell Prolif; 2005 Apr; 38(2):77-86. PubMed ID: 15842252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.